Results 11 to 20 of about 14,134 (231)

Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study. [PDF]

J Dermatol
Palmoplantar pustulosis (PPP) is a chronic skin disease characterized by erythema, pustules, and desquamation of the palms and soles. PPP epidemiological data are scarce.
Jo SJ, Kim BS, Kim DH, Kim JH, Park CW, Son SW, Ahn J, Lee JY, Jeong KH, Kim Y, An J, Park CJ, Youn SW.   +12 more
europepmc   +3 more sources

Successful treatment of palmoplantar pustulosis with topical ruxolitinib. [PDF]

J Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 12, Page 1591-1593, December 2025.
Cramer N, Wellmann P, Schön MP, Mössner R.   +3 more
europepmc   +3 more sources

Onychoscopy in Palmoplantar Psoriasis: A Comparative Study of Nonpustular Palmoplantar Psoriasis and Palmoplantar Pustulosis [PDF]

Dermatology Practical & Conceptual
Introduction: Palmoplantar psoriasis (PP) is classified as nonpustular psoriasis (NPPP) or palmoplantar pustulosis (PPP). Objective: We sought to shed light on the phenotypic diversity of nail psoriasis (NP) and conducted a thorough study of the ...
Ahu Yorulmaz
doaj   +3 more sources

Palmoplantar Pustulosis: A Case Report [PDF]

Clinical Practice and Cases in Emergency Medicine, 2020
Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. Most rashes are benign, but there are a select few that emergency physicians must be familiar with as delay in treatment could be life threatening.
Anne Dulski, Vince Varamo
doaj   +4 more sources

Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: Results from the randomized, phase 3 JumPPP study. [PDF]

J Dermatol
Palmoplantar pustulosis (PPP) is a chronic, debilitating skin disease of the palms and/or soles. We report the efficacy and safety of risankizumab (RZB), an interleukin 23 p19 inhibitor, from the JumPPP study (a phase 3, multicenter, randomized, placebo ...
Okubo Y, Murakami M, Kobayashi S, Tsuji S, Kishimoto M, Ikeda K, Jibiki M, Neimark E, Padilla B, Shen J, Peters S, Terui T.   +11 more
europepmc   +2 more sources

Emerging Therapies for Palmoplantar Pustulosis with a Focus on IL-23 Inhibitors. [PDF]

J Clin Med
Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disease characterized by recurrent pustules, erythema, and scaling on the palms and soles, leading to a significantly reduced quality of life.
Nam KH, Kim YS.
europepmc   +2 more sources

Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis. [PDF]

JCI Insight
Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disorder marked by erythematous pustules and desquamation on the palms and soles. While IL-17 pathways are implicated in PPP, IL-17 blockers have shown modest efficacy, underscoring the need ...
Do TH, Bogle R, Zhang H, Xing X, Gharaee-Kermani M, Raducu M, Fox J, Jiang R, Plazyo O, Harms PW, Nakamura M, Xing E, Gilliet M, Billi AC, Kahlenberg JM, Modlin RL, Uluckan O, Tsoi LC, Gudjonsson JE.   +18 more
europepmc   +2 more sources

Recalcitrant palmoplantar pustulosis controlled with dupilumab [PDF]

JAAD Case Reports, 2023
Hannah D. Smith, BA, Liliana Montoya, MD, Anna De Benedetto, MD   +2 more
doaj   +4 more sources

Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study. [PDF]

Adv Ther
Palmoplantar pustulosis (PPP) is a debilitating skin condition characterized by pustules, erythema, and scales on the palms and soles. Treatment adherence in psoriatic diseases is suboptimal.
Feldman SR, Gao R, Bohn RL, Gray S, Déruaz-Luyet A, Wu JJ.   +5 more
europepmc   +2 more sources

Recalcitrant Palmoplantar Pustulosis: Have You Considered Allergic Contact Dermatitis? [PDF]

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Palmoplantar pustulosis (PPP) is a chronic and relapsing disease of the palms and soles, which tends to be difficult to treat. Classically it was described as a subtype of psoriasis.
José Neves, A. Brasileiro, P. Mendes-Bastos   +2 more
doaj   +4 more sources